To test the effects of AD-MSCs treatment on the apoptosis of neural cells in the injured brain, we investigated the protein level of NeuN by immunohistochemistry and the mRNA level of NeuN and Bax/Bcl-2 by qPCR. The gene discussed is BCL2; the disease is Alzheimer disease.